https://www.openbell.ai/ 2026-09-29T13:59:22.235Z hourly 1.0 https://www.openbell.ai/support 2026-09-29T13:59:22.235Z monthly 0.7 https://www.openbell.ai/privacy 2026-09-29T13:59:22.235Z monthly 0.5 https://www.openbell.ai/terms 2026-09-29T13:59:22.235Z monthly 0.5 https://www.openbell.ai/feed.json 2026-09-29T13:59:22.235Z hourly 0.8 https://www.openbell.ai/news/SNPS:1790690297026 2026-09-29T13:58:17.026Z daily 0.9 https://cdn.brandfetch.io/SNPS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Synopsys Stock Climbs as HSBC Upgrades Software Giant on AI Growth Tailwinds Synopsys Inc. (NASDAQ: SNPS) shares rose 1.74% to $432.32 following an upgrade by HSBC analyst Frank Lee, who changed the rating from Hold to Buy and increased the 12-month price target from $490 to $700. The upgrade is attributed to Synopsys's transformation into a high-growth company driven by advancements in artificial intelligence, as well as a favorable outlook after recent valuation pullbacks related to concerns over revenue exposure to China and integration risks with Ansys. The recent launch of Multiphysics Fusion, a combined product with Ansys, indicates that integration fears are subsiding. https://www.openbell.ai/news/PLUG:1790690193745 2026-09-29T13:56:33.745Z daily 0.9 https://cdn.brandfetch.io/PLUG/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Plug Power, Maintains $7 Price Target HC Wainwright & Co. analyst Amit Dayal has reiterated a 'Buy' rating on Plug Power (NASDAQ: PLUG) and maintained a price target of $7 for the stock. https://www.openbell.ai/news/STLA:1790690143300 2026-09-29T13:55:43.300Z daily 0.9 https://cdn.brandfetch.io/STLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Stellantis To Suspend Production At Three French Plants' - Les Echos Stellantis has announced the suspension of production at three of its plants in France, implementing partial unemployment measures. This decision is part of the company's strategy to address current market challenges. The affected facilities are expected to impact overall production capacity, although specific financial implications have not been disclosed. https://www.openbell.ai/news/PIPR:1790690115017 2026-09-29T13:55:15.017Z daily 0.9 https://cdn.brandfetch.io/PIPR/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Piper Sandler Holds Talks to Buy Perella Weinberg' - WSJ Exclusive Piper Sandler is in discussions to acquire Perella Weinberg Partners, according to a report by the Wall Street Journal. This potential merger could significantly impact the investment banking landscape. The talks are still in the early stages, and no financial terms have been disclosed at this time. https://www.openbell.ai/news/CCL:1790690077896 2026-09-29T13:54:37.896Z daily 0.9 https://cdn.brandfetch.io/CCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Carnival shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY26 adjusted EPS guidance above estimates. openbell Financial News https://www.openbell.ai/news/HYLN:1790690023823 2026-09-29T13:53:43.823Z daily 0.9 https://cdn.brandfetch.io/HYLN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Craig-Hallum Initiates Coverage On Hyliion Holdings with Buy Rating, Announces Price Target of $7 Craig-Hallum analyst Eric Stine has initiated coverage on Hyliion Holdings (AMEX: HYLN) with a Buy rating. The firm has set a price target of $7 for the company's stock. https://www.openbell.ai/news/JPM:1790689863546 2026-09-29T13:51:03.546Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/29/Jamie-Dimon-Attends-Ceremony-For-Final-S.jpg?width=250&height=187 Jamie Dimon Proposes 'Big, Beautiful' Free Trade Pact Between US and Europe to Counter China: 'An Economic and Geopolitical Game Changer' Jamie Dimon, CEO of JPMorgan Chase & Co. (NYSE: JPM), has proposed a comprehensive plan to enhance the U.S.-Europe trade relationship and strengthen ties with Western allies. His proposal includes negotiating a significant free trade agreement with Europe, which could also involve other democratic nations, aiming to counter China's economic influence. Dimon emphasizes the need for stronger domestic economic policies in the U.S. to achieve 3% annual growth, which he believes could have increased GDP per capita by $20,000 over the past two decades. https://www.openbell.ai/news/PPCB:1790689603116 2026-09-29T13:46:43.116Z daily 0.9 https://cdn.brandfetch.io/PPCB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Propanc Biopharma Q4 EPS $(0.10) Propanc Biopharma (NASDAQ: PPCB) reported a quarterly loss of $(0.10) per share for Q4. No additional financial figures or strategic changes were mentioned in the article. https://www.openbell.ai/news/BILL:1790689597575 2026-09-29T13:46:37.575Z daily 0.9 https://cdn.brandfetch.io/BILL/w/400/h/400?c=1idopYfmtR7ZKg8QMud BILL And Blackbaud Announce New Strategic Partnership To Simplify Accounts Payable Process For Nonprofit And Education Finance Teams BILL and Blackbaud have announced a strategic partnership aimed at simplifying the accounts payable process for nonprofit and education finance teams. The partnership will integrate BILL's payment-processing capabilities into Blackbaud Financial Edge NXT's Payment Assistant, streamlining the invoice and payment workflow. This collaboration addresses the significant time investment finance teams currently spend on manual accounts payable tasks, allowing them to focus more on their organizational missions. https://www.openbell.ai/news/PGY:1790689296886 2026-09-29T13:41:36.886Z daily 0.9 https://cdn.brandfetch.io/PGY/w/400/h/400?c=1idopYfmtR7ZKg8QMud StoneX Reiterates Buy on Pagaya Technologies, Maintains $33 Price Target StoneX analyst Mark Palmer has reiterated a Buy rating on Pagaya Technologies (NASDAQ: PGY) and has maintained a price target of $33 for the stock. https://www.openbell.ai/news/AMD:1790689142901 2026-09-29T13:39:02.901Z daily 0.9 https://cdn.brandfetch.io/AMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud StoneX Reiterates Buy on Advanced Micro Devices, Maintains $685 Price Target StoneX analyst Cody Acree has reiterated a Buy rating on Advanced Micro Devices (NASDAQ: AMD) and has maintained a price target of $685 for the stock. https://www.openbell.ai/news/GRRR:1790688961563 2026-09-29T13:36:01.563Z daily 0.9 https://cdn.brandfetch.io/GRRR/w/400/h/400?c=1idopYfmtR7ZKg8QMud StoneX Initiates Coverage On Gorilla Tech Gr with Buy Rating, Announces Price Target of $25 StoneX analyst Gary Mobley has initiated coverage on Gorilla Tech Gr (NASDAQ: GRRR) with a Buy rating. The analyst has set a price target of $25 for the stock. https://www.openbell.ai/news/GPRK:1790688922871 2026-09-29T13:35:22.871Z daily 0.9 https://cdn.brandfetch.io/GPRK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Geopark CEO Felipe Bayon Says To Begin Operations At Venezuela's Bare Oilfield In December; Co Has Identified Some 80 Opportunities For Horizontal Drilling In Venezuela Geopark CEO Felipe Bayon announced that the company will commence operations at Venezuela's Bare Oilfield in December. Additionally, Geopark has identified approximately 80 opportunities for horizontal drilling in the region, indicating a significant potential for expansion in its operations. https://www.openbell.ai/news/COSM:1790688872063 2026-09-29T13:34:32.063Z daily 0.9 https://cdn.brandfetch.io/COSM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cosmos Health’s CosmoFarm Reports Q2 Revenue Of Over $15M, $60M Annualized Run Rate; Says Robotics, Automation And AI-Enabled Systems Across Procurement, Inventory And Order Execution, With Capacity That Could Support A Further $40M Or More In Annual Revenue, Which Would Provide Infrastructure For Annualized Revenue Above $100M Cosmos Health's subsidiary, CosmoFarm, reported record Q2 2026 revenue exceeding $15 million, leading to an annualized run-rate of over $60 million. This marks a 4.3x increase in revenue since the company's acquisition in 2017, with a compound annual growth rate (CAGR) of approximately 18%. The company is leveraging robotics, automation, and AI-enabled systems to potentially support an additional $40 million in annual revenue, aiming for a total annualized revenue above $100 million. Cosmos Health has set a 2029 revenue guidance of $200.6 million. https://www.openbell.ai/news/ONCY:1790688812790 2026-09-29T13:33:32.790Z daily 0.9 https://cdn.brandfetch.io/ONCY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oncolytics Biotech Publishes Data On Pelareorep Immunotherapy In Proceedings Of The National Academy Of Sciences Oncolytics Biotech Inc. (NASDAQ: ONCY) announced the publication of data regarding its investigational immunotherapy, pelareorep, in the Proceedings of the National Academy of Sciences. The study demonstrates pelareorep's potential to convert an immunologically inactive liver cancer tumor microenvironment into one that is active and responsive to immune-based therapies. The findings highlight the therapy's ability to enhance protective immune responses and promote the expansion of tumor-infiltrating lymphocytes. https://www.openbell.ai/news/SMA:1790688711082 2026-09-29T13:31:51.082Z daily 0.9 https://cdn.brandfetch.io/SMA/w/400/h/400?c=1idopYfmtR7ZKg8QMud SmartStop Self Storage REIT Investing ~$54M Into Canadian JV; Anticipates To Acquire Two Properties In Las Vegas, North Carolina For ~$37M; Plans To Dispose Off Select Properties In Noncore Markets Targeting $75M - $125M SmartStop Self Storage REIT, Inc. is investing approximately $140 million in strategic initiatives across Canada and the U.S., including a CAD $74 million (USD $54 million) investment in a Canadian joint venture fund for a 50% General Partner and 34% Limited Partner interest in 14 self-storage properties. The company plans to acquire two properties in Las Vegas and Asheville for around $37 million, totaling over 186,000 net rentable square feet. Additionally, SmartStop aims to sell select properties in noncore markets, targeting $75 million to $125 million in property sales starting in early 2027. https://www.openbell.ai/news/MUY:1790688601102 2026-09-29T13:30:01.102Z daily 0.9 https://cdn.brandfetch.io/MUY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halt status updated at 9:30:00 AM ET: Quotation Resumption: IPO security released for quotation openbell Financial News https://www.openbell.ai/news/CTAS:1790688598646 2026-09-29T13:29:58.646Z daily 0.9 https://cdn.brandfetch.io/CTAS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Argus Research Maintains Buy on Cintas, Raises Price Target to $240 Argus Research analyst John Eade has reiterated a Buy rating on Cintas (NASDAQ: CTAS) and increased the price target from $230 to $240. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/GLND:1790688558435 2026-09-29T13:29:18.435Z daily 0.9 https://cdn.brandfetch.io/GLND/w/400/h/400?c=1idopYfmtR7ZKg8QMud Greenland Energy Responds To Short-Seller Report, Defending Its Exploration Strategy, Finances And 13B-Barrel Potential; Says "GLND Is An Exploration-Stage Oil And Gas Company Focused On The Development And Advancement Of Its Exploration Activities In Greenland. We Currently Have No Earnings, No Production And No Proved Reserves. Our First Well Has Not Been Drilled. We Said All Of This Ourselves In Our Prospectus And Our 10-Q, In Plainer Language Than Fugazi Uses." Greenland Energy Company (GLND) has responded to a report from Fugazi Research labeling it 'uninvestable,' emphasizing that it is an exploration-stage oil and gas company with no current earnings, production, or proved reserves. The company claims a potential resource of up to 13 billion barrels, based on an independent estimate, but acknowledges that drilling is necessary to confirm these figures. Greenland Energy also clarified its financial position, stating it has approximately $28 million in cash, with a significant portion allocated to capitalized assets and prepaid exploration costs. The company aims to secure permits and commence drilling to validate its resource potential. https://www.openbell.ai/news/LLY:1790688196146 2026-09-29T13:23:16.146Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/29/Zepbound.jpg?width=250&height=187 Wegovy or Zepbound? Eli Lilly Shows Zepbound Outperforms Wegovy in New Weight Loss Data Eli Lilly and Co. presented new data indicating that its weight loss medication Zepbound outperforms Novo Nordisk's Wegovy, showing a 4.5% greater weight loss at the 15 mg dose after 72 weeks. Additionally, Zepbound users had four times the odds of losing 20% or more of their body weight compared to Wegovy. Eli Lilly's shares rose 0.36% to $118.90, while Novo Nordisk's shares fell 1.38% to $38.17 during premarket trading. https://www.openbell.ai/news/PEP:1790688158428 2026-09-29T13:22:38.428Z daily 0.9 https://cdn.brandfetch.io/PEP/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Downgrades PepsiCo to Neutral, Lowers Price Target to $138 JP Morgan analyst Andrea Teixeira has downgraded PepsiCo (NASDAQ: PEP) from Overweight to Neutral, reducing the price target from $170 to $138. This change reflects a shift in the firm's outlook on the company's performance. https://www.openbell.ai/news/MTUS:1790688109219 2026-09-29T13:21:49.219Z daily 0.9 https://cdn.brandfetch.io/MTUS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Metallus Receives $995M, Five-Year U.S. Defense Logistics Agency Order For Steel Supply Metallus (NYSE: MTUS) has been awarded a five-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the U.S. Defense Logistics Agency (DLA) to supply steel for defense applications, with a maximum value of $995 million. The contract allows the DLA to issue delivery orders during the contract term, but the ceiling amount does not guarantee that the full amount will be purchased. https://www.openbell.ai/news/VEON:1790687949836 2026-09-29T13:19:09.836Z daily 0.9 https://cdn.brandfetch.io/VEON/w/400/h/400?c=1idopYfmtR7ZKg8QMud VEON Unit Beeline Kazakhstan Partners With Starlink To Launch Direct-To-Device Connectivity VEON's unit Beeline Kazakhstan has partnered with Starlink to launch Starlink Mobile, enabling direct-to-device connectivity. Customers can manage this service through Janymda, Beeline's super app, enhancing access to digital services. This technology aims to improve connectivity in remote areas and during natural disasters, benefiting emergency services and individuals in hard-to-reach locations. https://www.openbell.ai/news/BLMN:1790687943692 2026-09-29T13:19:03.692Z daily 0.9 https://cdn.brandfetch.io/BLMN/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Upgrades Bloomin Brands to Neutral, Raises Price Target to $13 JP Morgan analyst John Ivankoe has upgraded Bloomin Brands (NASDAQ: BLMN) from Underweight to Neutral. The price target for the stock has been raised from $6 to $13. https://www.openbell.ai/news/NVDA:1790687924708 2026-09-29T13:18:44.708Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/29/Taipei--Taiwan---19-Mar-2022-Company-Off.jpg?width=250&height=187 Nvidia, AMD Lobby Trump Administration to Halt Potential Chip Export Restrictions to China: Report Nvidia Corporation (NASDAQ: NVDA) and Advanced Micro Devices, Inc. (NASDAQ: AMD) are lobbying the Trump administration to prevent potential export restrictions on chips to China. The companies have intensified their engagement with the White House and the Commerce Department, urging lawmakers to exclude such restrictions from the annual defense policy bill. Nvidia's revenue from China fell to $4.55 billion in the first quarter from $9.66 billion a year earlier, while year-to-date stock prices for Nvidia and AMD increased by 22.71% and 183.84%, respectively. https://www.openbell.ai/news/CCL:1790687891157 2026-09-29T13:18:11.157Z daily 0.9 https://cdn.brandfetch.io/CCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Carnival Sees Q4 Adj EPS $0.20 vs $0.26 Est Carnival Corporation (NYSE: CCL) reported a Q4 adjusted earnings per share (EPS) of $0.20, falling short of the analyst estimate of $0.26. This performance indicates a potential shortfall in expected profitability for the quarter. https://www.openbell.ai/news/CCL:1790687870948 2026-09-29T13:17:50.948Z daily 0.9 https://cdn.brandfetch.io/CCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Carnival Raises FY2026 Adj EPS Guidance from $2.22 to $2.24 vs $2.22 Est Carnival (NYSE: CCL) has raised its fiscal year 2026 adjusted earnings per share (EPS) guidance from $2.22 to $2.24, surpassing the previous analyst estimate of $2.22. This adjustment indicates a positive outlook for the company's financial performance in the upcoming fiscal year. https://www.openbell.ai/news/XNDU:1790687868739 2026-09-29T13:17:48.739Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/29/Stock-chartbenzingaai2023-stock-market-c.png?width=250&height=187 Xanadu Stock Rises After Bluefors Deal, Fresh RBC Capital Coverage Xanadu Quantum Technologies Ltd. (NASDAQ: XNDU) shares rose 5.66% to $5.03 following the announcement of a multi-million-dollar partnership with Bluefors to develop cryogenic infrastructure for quantum computing. This collaboration aims to create a high-performance cryogenic prototype that eliminates the need for traditional cryoplants in utility-scale quantum data centers. Additionally, RBC Capital initiated coverage on Xanadu with an Outperform rating and a price target of $16. https://www.openbell.ai/news/AMD:1790687804504 2026-09-29T13:16:44.504Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/29/Advanced-Micro-Devices-Turnaround-Under-.jpg?width=250&height=187 Why AMD Is Spending $8.2 Billion On World Labs Advanced Micro Devices Inc. (AMD) is acquiring World Labs for $8.2 billion in an all-stock deal to enhance its capabilities in next-generation AI workloads and strengthen its hardware-software ecosystem. The acquisition will provide AMD access to World Labs' spatial-intelligence research, which is crucial for developing AI applications. World Labs' founder, Fei-Fei Li, will join AMD as executive vice president and chief scientist. Following the news, AMD shares rose 1.05% to $614.25 in premarket trading. https://www.openbell.ai/news/AMZE:1790687801945 2026-09-29T13:16:41.945Z daily 0.9 https://cdn.brandfetch.io/AMZE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Amaze Holdings, A $5M Market Cap Company Announces It Has Executed A Binding Letter of Intent To Acquire BullionFX Assets Including Its Core Platform Alchemy In a All-Stock Deal Valued At $155M; The Transaction, If Consummated, Will Result In Significant Issuance Of Amaze Common Stock To BullionFX Amaze Holdings, Inc. (NYSE: AMZE) has announced a binding Letter of Intent to acquire BullionFX assets, including its core platform Alchemy, in an all-stock deal valued at approximately $155 million. This acquisition aims to expand Amaze's operations into gold-backed digital-asset infrastructure amidst a resurgence in cryptocurrency markets and significant growth in the stablecoin sector, which saw a transaction volume of $1.79 trillion in June 2026, a 125% increase year-on-year. The transaction will involve a substantial issuance of Amaze common stock to BullionFX, pending due diligence and regulatory approvals. https://www.openbell.ai/news/VUZI:1790687792050 2026-09-29T13:16:32.050Z daily 0.9 https://cdn.brandfetch.io/VUZI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Vuzix Rolls Out Vuzix Strike Display Platform, Starts Initial Shipment Vuzix Corporation (NASDAQ: VUZI) has launched the Vuzix Shrike, a configurable waveguide display platform aimed at defense, security, and first responder applications. The company has commenced initial shipments of the Shrike units to customers for evaluation and integration into custom wearable display systems. https://www.openbell.ai/news/ABCL:1790687771850 2026-09-29T13:16:11.850Z daily 0.9 https://cdn.brandfetch.io/ABCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Initiates Coverage On AbCellera Biologics with Overweight Rating, Announces Price Target of $17 JP Morgan analyst Brian Cheng has initiated coverage on AbCellera Biologics (NASDAQ: ABCL) with an Overweight rating. The firm has set a price target of $17 for the company's stock. https://www.openbell.ai/news/SMMT:1790687560947 2026-09-29T13:12:40.947Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/29/AstraZeneca-plc-company-logo-displayed-o.jpg?width=250&height=187 AstraZeneca Invests in Summit Therapeutics after Year of Speculation AstraZeneca Plc has agreed to invest $2 billion in Summit Therapeutics Inc to support the development of ivonescimab in combination with antibody-drug conjugates across various tumor types. The companies have also entered a clinical collaboration to evaluate sonesitatug vedotin (Sone-Ve) alongside ivonescimab, with plans to initiate trials in gastrointestinal cancers soon. Following the announcement, Summit's shares rose by 17.57% to $18.20, while AstraZeneca's shares increased by 0.99% to $167.79 during premarket trading. https://www.openbell.ai/news/QMLS:1790687492960 2026-09-29T13:11:32.960Z daily 0.9 https://cdn.brandfetch.io/QMLS/w/400/h/400?c=1idopYfmtR7ZKg8QMud QumulusAI Inks Two, Three-Year $240.9M Agreements With AI Inference Clients For Over 2K NVIDIA Blackwell B300 GPUs QumulusAI (Nasdaq: QMLS) has secured two three-year agreements with AI inference clients, totaling a combined value of $240.9 million. These contracts will cover over 2,000 NVIDIA Blackwell B300 GPUs across two dedicated clusters, enhancing the company's infrastructure for AI computing. https://www.openbell.ai/news/TXG:1790687467993 2026-09-29T13:11:07.993Z daily 0.9 https://cdn.brandfetch.io/TXG/w/400/h/400?c=1idopYfmtR7ZKg8QMud 10x Genomics Begins Commercial Shipments Of Its Transcriptome Analysis Tool Atera 10x Genomics has commenced commercial shipments of its transcriptome analysis tool, Atera, which is now being utilized by researchers globally across various fields, including oncology and neurodegenerative diseases. The company reported that booked orders for Atera have surpassed the initial expectation of 40 instruments to be shipped by 2026, indicating strong demand. The platform is expected to support a wide range of research applications, including cell and tissue atlasing and biomarker research. https://www.openbell.ai/news/FCEL:1790687415852 2026-09-29T13:10:15.852Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/29/FuelCell-Energy.jpg?width=250&height=187 FuelCell Energy Stock Surges Following Oppenheimer Initiation: What Investors Need to Know FuelCell Energy Inc. (NASDAQ: FCEL) shares surged 9.54% to $17.68 in premarket trading following Oppenheimer's initiation of coverage with an Outperform rating and a price target of $24.00. Analyst Colin Rusch highlighted the company's plans to expand production capacity to 500 megawatts per year by FY2029, supported by a $3.3 billion backlog and over 450 MW in capacity agreements. FuelCell's healthy balance sheet, with approximately $737 million in cash, positions it well for achieving positive cash flow as it executes its expansion strategy. https://www.openbell.ai/news/AMSS:1790687359672 2026-09-29T13:09:19.672Z daily 0.9 https://cdn.brandfetch.io/AMSS/w/400/h/400?c=1idopYfmtR7ZKg8QMud AMASS Brands Group's AMASS Electrolytes Reports ~$1.4M Annualized Revenue Run Rate AMASS Brands Group (NASDAQ: AMSS) announced that its AMASS Electrolytes line has reached an annualized revenue run rate of approximately $1.4 million since its launch in May 2026. Revenue for September from sparkling electrolyte mixers and hydration powders was about $116,000, representing an 89% increase from August and more than triple the revenue from June. https://www.openbell.ai/news/ROL:1790687319948 2026-09-29T13:08:39.948Z daily 0.9 https://cdn.brandfetch.io/ROL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Underweight on Rollins, Lowers Price Target to $27 Wells Fargo analyst Jason Haas has maintained an Underweight rating on Rollins (NYSE: ROL) and has reduced the price target from $32 to $27. This adjustment reflects a more cautious outlook on the company's performance. https://www.openbell.ai/news/TXG:1790687312788 2026-09-29T13:08:32.788Z daily 0.9 https://cdn.brandfetch.io/TXG/w/400/h/400?c=1idopYfmtR7ZKg8QMud 10x Genomics Launches NVIDIA-Accelerated Sentira Spatial Analysis, Cutting Spatial Data Processing Times From Hours To Minutes 10x Genomics, Inc. (NASDAQ: TXG) has launched Sentira Spatial Analysis, a new cloud analysis platform that significantly reduces spatial data processing times from hours to minutes. This innovation aims to streamline the analysis process for researchers, allowing for rapid, iterative analysis of complex biological data. The launch comes as the company enhances its offerings in spatial biology, coinciding with the shipping of its Atera product, which facilitates faster data generation at scale. https://www.openbell.ai/news/ABBV:1790687309914 2026-09-29T13:08:29.914Z daily 0.9 https://cdn.brandfetch.io/ABBV/w/400/h/400?c=1idopYfmtR7ZKg8QMud AbbVie And Valkai Collaborate To Accelerate Pace Of Scientific Innovation's Reach To Patients AbbVie (NYSE: ABBV) has announced a partnership with Valkai, a life sciences AI platform, to enhance its artificial intelligence infrastructure. This collaboration aims to accelerate the delivery of scientific innovations to patients by improving efficiency in clinical research and reducing development timelines. https://www.openbell.ai/news/AMG:1790687305185 2026-09-29T13:08:25.185Z daily 0.9 https://cdn.brandfetch.io/AMG/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Reiterates Buy on Affiliated Managers Group, Maintains $512 Price Target TD Cowen analyst Bill Katz has reiterated a 'Buy' rating on Affiliated Managers Group (NYSE: AMG) and has maintained a price target of $512 for the stock. This re-evaluation suggests confidence in the company's performance and potential for growth. https://www.openbell.ai/news/BRZE:1790687259774 2026-09-29T13:07:39.774Z daily 0.9 https://cdn.brandfetch.io/BRZE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Braze Signs Strategic Collaboration Agreement With AWS To Expand Generative AI, Industry Solutions And Personalized Customer Engagement At Scale Braze (NASDAQ: BRZE) has signed a strategic collaboration agreement with Amazon Web Services (AWS) to enhance generative AI capabilities and improve personalized customer engagement. This partnership aims to help brands accelerate innovation and integrate emerging technologies into their marketing workflows, leveraging AWS's global infrastructure and marketplace. The announcement was made during Braze's annual customer conference, Forge, held from September 28-30 in Las Vegas. https://www.openbell.ai/news/AMSS:1790687253998 2026-09-29T13:07:33.998Z daily 0.9 https://cdn.brandfetch.io/AMSS/w/400/h/400?c=1idopYfmtR7ZKg8QMud AMASS Brands Group's AMASS Electrolytes Reports ~$1.4M Annualized Revenue Run Rate AMASS Brands Group (NASDAQ: AMSS) announced that its AMASS Electrolytes line has reached an annualized revenue run rate of approximately $1.4 million following its launch in May 2026. September revenue from the product line, which includes sparkling electrolyte mixers and hydration powders, totaled around $116,000, marking an 89% increase from August and more than tripling June's revenue. https://www.openbell.ai/news/CAPS:1790687245422 2026-09-29T13:07:25.422Z daily 0.9 https://cdn.brandfetch.io/CAPS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Capstone Holding Retires ~85% Of Original $6.82M In Convertible Note Principal, Cuts Remaining Convertible Debt To $1M Capstone Holding Corp. (NASDAQ: CAPS) has retired approximately 85% of its original $6.82 million in convertible note principal, reducing the remaining balance to $1 million. The company has fully retired the first of its two convertible notes, originally issued in July 2025, and only the October 2025 note remains outstanding as it advances toward eliminating its remaining convertible debt. https://www.openbell.ai/news/GNSS:1790687159775 2026-09-29T13:05:59.775Z daily 0.9 https://cdn.brandfetch.io/GNSS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Genasys Receives $1.5M Orders For Its Voice Broadcast And Mass Notification Systems Genasys Inc. (NASDAQ: GNSS) has announced the receipt of $1.5 million in orders for its Long Range Acoustic Device (LRAD) and Acoustics systems. These voice broadcast and mass notification systems are intended for deployment in law enforcement, emergency warning, and energy sectors, both domestically and internationally. https://www.openbell.ai/news/LIMN:1790687128062 2026-09-29T13:05:28.062Z daily 0.9 https://cdn.brandfetch.io/LIMN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Liminatus Pharma Regains Compliance With Nasdaq’s Minimum Bid Price Rule Liminatus Pharma has regained compliance with Nasdaq's minimum bid price rule after its common stock closed above $1.00 per share for 13 consecutive trading days, from August 21, 2026, to September 9, 2026. Nasdaq has confirmed that the matter is now closed. https://www.openbell.ai/news/CYCU:1790687103168 2026-09-29T13:05:03.168Z daily 0.9 https://cdn.brandfetch.io/CYCU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cycurion Resolves Previously Announced John Doe Defamation Action In U.S. Against Undisclosed Defendant;. Defendant Admits Accusations Were False Against Co.; Permanent Ban On Trading Imposed On Defendant; Financial Terms Undisclosed Cycurion, Inc. (NASDAQ: CYCU) has resolved a defamation case in the U.S. District Court for the Eastern District of Virginia, where the anonymous defendant admitted to making false accusations against the company. The defendant has signed a retraction and issued a personal apology, and a permanent ban on trading has been imposed on them. Financial terms of the resolution have not been disclosed. https://www.openbell.ai/news/WMG:1790687047310 2026-09-29T13:04:07.310Z daily 0.9 https://cdn.brandfetch.io/WMG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Reiterates Buy on Warner Music Gr, Maintains $36 Price Target Guggenheim analyst Michael Morris has reiterated a Buy rating on Warner Music Group (NASDAQ: WMG) and has maintained a price target of $36 for the stock. This endorsement reflects confidence in the company's performance and market position. https://www.openbell.ai/news/AVD:1790687020203 2026-09-29T13:03:40.203Z daily 0.9 https://cdn.brandfetch.io/AVD/w/400/h/400?c=1idopYfmtR7ZKg8QMud American Vanguard To Acquire The U.S. Rights To Crop-Protection Brands Caparol, Evik, Prime+, And Agri-Flex From Syngenta; Terms Not Disclosed; Expects $7M+ Of Annual Net Sales From Four Brands American Vanguard has announced its acquisition of the U.S. rights to crop-protection brands Caparol, Evik, Prime+, and Agri-Flex from Syngenta, with the transaction expected to generate over $7 million in annual net sales. Although financial terms were not disclosed, the deal is anticipated to be accretive to earnings and improve American Vanguard's leverage ratio over the next year. The acquired products cater to various agricultural markets, including cotton, vegetables, sugarcane, pineapple, tobacco, and specialty crops, enhancing the company's portfolio and supporting its sales goals of $100 million in new product sales by 2030 and $600 million by 2028. https://www.openbell.ai/news/ICE:1790687001995 2026-09-29T13:03:21.995Z daily 0.9 https://cdn.brandfetch.io/ICE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Intercontinental Exchange Announces Wells Fargo Renews Its Agreement To Use MSP, ICE’s Mortgage Loan Servicing System Intercontinental Exchange, Inc. (NYSE: ICE) announced that Wells Fargo (NYSE: WFC) has renewed its long-term agreement to utilize ICE’s Mortgage Servicing Platform (MSP). This renewal will see Wells Fargo transition its entire home loan servicing portfolio to MSP, enhancing a partnership that has lasted over 35 years. Additionally, Wells Fargo will use ICE Business Intelligence for automating default servicing workflows and has started electronically registering mortgage loans on the MERS eRegistry.